Eliem Therapeutics Inc (ELYM)
10.16
+1.76
(+21.04%)
USD |
NASDAQ |
May 03, 16:00
10.14
-0.02
(-0.15%)
Pre-Market: 20:00
Eliem Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Alpine Immune Sciences Inc | 0.00 |
Candel Therapeutics Inc | -- |
Cyclacel Pharmaceuticals Inc | 0.00 |
Lipocine Inc | 0.00 |
GlycoMimetics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 110.47M |
Total Liabilities (Quarterly) | 2.87M |
Shareholders Equity (Quarterly) | 107.60M |